Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05142566 · ClinicalTrials.gov registry record · NA
MANTA Ultrasound Closure Study
A NA study, sponsored by Essential Medical.
- Terminated
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT05142566 is a NA study that was terminated before completion, run by Essential Medical. The registered enrollment target is 17 participants.
The verdict
NCT05142566, a NA study, was terminated before completion, sponsored by Essential Medical.
- TERMINATED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
Demonstrate the safety of MANTA Vascular Closure Device (VCD) ultrasound (U/S) guided closure in patients undergoing elective TAVR procedures with planned percutaneous femoral arterial access.
Interventions
- DEVICE MANTA Vascular Closure Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2022-08-09 |
| Est. Completion | 2023-01-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05142566
The ClinicalTrials.gov registry entry for NCT05142566 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Essential Medical, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MANTA Vascular Closure Device is the first listed.
NCT05142566 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05142566 about?
NCT05142566 is a clinical study titled "MANTA Ultrasound Closure Study". Demonstrate the safety of MANTA Vascular Closure Device (VCD) ultrasound (U/S) guided closure in patients undergoing elective TAVR procedures with planned percutaneous femoral arterial access.
What is the current status of trial NCT05142566?
This trial is currently terminated. It is a NA study. The enrollment target is 17 participants. The study started on 2022-08-09. Estimated completion is 2023-01-11.
What interventions are being tested in trial NCT05142566?
The interventions under investigation include: MANTA Vascular Closure Device (DEVICE).
Who is sponsoring clinical trial NCT05142566?
This trial is sponsored by Essential Medical, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.